Zimbabwe To Launch Mental Health Investment Case Report

ZIMBABWE is set to launch the Mental Health Investment case report in October which will be used mainly as an advocacy tool providing quantified evidence of the long-term health, social and economic benefits of investment in mental health. By Patricia Mashiri Speaking during a mental health case investment case inception virtual meeting, Mr Gwati Gwati, the  Ministry of Health and Child Care (MoHCC) Health Economist said the Mental health case investment case provides quantification of the costs of mental health conditions to the health sector and to the national economy…

Read More

Protect Corruption Whistleblowers- UN Urges Zim Gvt

THE United Nations (UN) Zimbabwe country representative, Ms. Maria Ribeiro’s has on called government and all organisations dealing with corruption to ensure the safety and protection of whistle blowers so as to encourage the culture of reporting corruption in the country. By Michael Gwarisa Speaking at the opening event of a two day National Workshop on Whistleblower protection in Harare, Ms Ribeiro said whistleblowers play a pivotal in the exposing of corrupt activities in the public and private sector. We all need to acknowledge that information about acts of corruption…

Read More

Ignore Zoonotic Diseases At Own Peril- Dr Marume

ONE of Zimbabwe’s leading Veterinary Pharmacist, Dr Amos Marume has called on government and the health sector at large to invest heavily towards Zoonotic disease surveillance and early detection in order to avoid and contain future diseases outbreaks. By Michael Gwarisa Zoonotic Diseases are disease transmitted from animals to humans and Dr Marume’s call comes in the midst of a COVID-19 pandemic that is also believed to have originated from bats and other wild animals. Addressing delegates at the just ended Retail Pharmacists Association conference in Harare, Dr Marume said…

Read More

WHO Recommends Newest COVID-19 Treatment…As MSF Calls For Equal Access To The Medications

THE World Health Organization (WHO) recommended the two-drug treatment cocktail, casirivimab/imdevimab, for people with COVID-19. HealthTimes Reporter The development comes in the midst of calls by the Doctors Without Borders (MSF) on the US pharmaceutical corporation Regeneron, the manufacturer and patent holder of these drugs, to take immediate actions to ensure the medications are affordable and accessible for everyone who needs them and forego any monopoly on these new treatments. Given the massive need for COVID-19 medicines around the world, Regeneron should make casirivimab and imdevimab available at a reasonable…

Read More